Tizanidine Hydrochloride Capsule
Product Images NDC 62332-491

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 62332-491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 2 mg

Each capsule contains 229mg of tizanidine hydrochloride, USP and corresponds to NDC §2332-491-30. The capsules are manufactured by Alembic Pharmaceuticals Limited in their Formulation Division located in Panelav 389350, Gujarat, India. The package contains 30 capsules measuring 28x30mm. This product is manufactured for Alembic Pharmaceuticals in Bedminster, NJ, USA. Prescribing information and other details may be found in the packaging.*

FDA Label Image

Tizanidine 4 mg

This is a medication called Tizanidine with a potency of 4 mg per capsule. It is recommended to read the package insert for information on prescription. The capsules should be stored in a child-resistant container. They were manufactured by Alembic Pharmaceuticals Limited in Panelav, Gujarat, India, and distributed by Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA. The medication is available in a package containing 30 capsules. The drug is regulated under controlled temperature and humidity conditions. It is important to keep this medication out of reach of children. "Zanaflex®" is a registered trademark of Acorda Therapeutics, Inc.*

FDA Label Image

Tizanidine 6 mg

FDA Label Image

Tizanidine-figure-1.jpg (Tizanidine Figure 1)

FDA Label Image

Tizanidine-figure-2.jpg (Tizanidine Figure 2)

FDA Label Image

Tizanidine-figure-3.jpg (Tizanidine Figure 3)

This appears to be a medical report discussing the improvement in Ashworth Score for patients taking zanaflex (a muscle relaxant) at a mean dose of 28.8mg. The report mentions a study lasting 3 weeks with the last observation being carried forward.*

FDA Label Image

Tizanidine-str.jpg (Tizanidine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.